Fundraising Fox

Expansion Therapeutics

Del Mar, US · Founded 2016 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

PS
Paul StoneExecutive Officer
YH
Yujiro HataDirector
KF
Kevin ForrestExecutive Officer, Director
SR
Scott RocklageExecutive Officer, Director
MD
Matthew DisneyDirector
JH
Jason HaflerDirector

Investors · 2

5AM VenturesBoston · $100K – $4M
Sanofi VenturesreportedCambridge · $5Mvia Jason P. Hafler · board

Reported raises · per SEC filings

Form D private placements
▶$48MraisedOct 2021 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Renato Skerlj, Ph.D.Executive Officer, Director
  • Laura Tadvalkar, Ph.D.Director
  • Andy Phillips, Ph.D.Director
  • Scott Rocklage, Ph.D.Director
  • Beth Seidenberg, M.D.Director
Offering amount
$80.1M
Amount sold
$48M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.3MraisedJan 2018 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin Forrest, Ph.D.Executive Officer, Director
  • Campbell Murray, M.B.B.S., M.B.A.Director
  • Yujiro Hata, M.B.A.Director
  • Matthew Disney, Ph.D.Director
  • Beth Seidenberg, M.D.Director
  • Scott Rocklage, Ph.D.Director
  • Jason Hafler, Ph.D.Director
Offering amount
$55.3M
Amount sold
$25.3M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJun 2017 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul StoneExecutive Officer
  • Yujiro HataDirector
  • Kevin ForrestExecutive Officer, Director
  • Scott RocklageExecutive Officer, Director
  • Matthew DisneyDirector
  • Jason HaflerDirector
Offering amount
$5M
Amount sold
$5M
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.